Authors:

Guillochon E, Fraering J, Joste V, Kamaliddin C, Vianou B, Houzé L, Baudrin LG, Faucher JF, Aubouy A, Houze S, Cot M, Argy N, Stool O, Bertin GI; NeuroCM group.

Review: J Infect Dis

Date: 2022

Pagination:  2022;225(12):2187-2196

gwladys

Gwladys BERTIN

ITHE Manager, therapeutic innovations LABO Research Engineer, Head of the LAB Axis
gwladys.bertin@ird.fr
Faculty of Pharmacy, Paris
JEREMYFRAERING

Jeremy FRAERING

PhD student
jeremy.fraering@ird.fr
Paris
michel_cot

Michael Cot

MEDS manager Emeritus Research Director
michel.cot@ird.fr
Other experience
Nicolas ARGY

Nicolas ARGY

ITHE Manager, HOPE therapeutic innovations, host-pathogen interactions University lecturer-hospital practitioner
nicolas.argy@gmail.com
Faculty of Pharmacy, Paris
avatar

Sandrine HOUZE

ITHE Manager, Therapeutic Innovations Deputy Director of the UMR, University Professor-Hospital Practitioner
sandrine.houze@bch.aphp.fr
Faculty of Pharmacy, Paris
avatar man

Valentin JOSTE

MEDS manager PhD student
valentin.joste@gmail.com
Faculty of Pharmacy, Paris